T-cell masthead image

R. Christopher Cavalli, PhD

Vice President, Biopharmaceutical Development

R. Christopher Cavalli has over 20 years of experience in the pharmaceutical and biotechnology industry, in the areas of pharmaceutical development, manufacturing and analytical testing.  Prior to joining Soligenix, Dr. Cavalli worked as a manager/director at Pharmalytic (a subsidiary of ColorCon), Discovery Laboratories, Cytogen, and most recently, Hemispherx Biopharma where he was responsible for the day to day operation of their active pharmaceutical ingredient manufacturing facility.  In these positions he was responsible for Quality Control, Quality Assurance, Process Development, Manufacturing and Regulatory.  Dr. Cavalli received his PhD in the Department of Chemistry at Temple University and did postdoctoral studies in the Biochemistry Department at Temple University School of Medicine.